These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38956085)

  • 1. Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey.
    Sun C; Jia Y; Li H; Qiao X; Tang M; Geng M; Jones E; Pike J; Unsworth M; Hu M
    Sci Rep; 2024 Jul; 14(1):15183. PubMed ID: 38956085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
    Jones E; Pike J; Marshall T; Ye X
    BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.
    Culpepper L; Martin A; Nabulsi N; Parikh M
    Adv Ther; 2024 May; 41(5):1860-1884. PubMed ID: 38466558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct and indirect costs of Dravet Syndrome.
    Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
    Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of multiple sclerosis in Japan.
    Nohara C; Hase M; Liebert R; Wu N
    J Med Econ; 2017 Dec; 20(12):1290-1298. PubMed ID: 28849983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    Mult Scler Relat Disord; 2022 Sep; 65():103971. PubMed ID: 35843012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States.
    Nalamachu S; Robinson RL; Viktrup L; Cappelleri JC; Bushmakin AG; Tive L; Mellor J; Hatchell N; Jackson J
    Postgrad Med; 2021 Jan; 133(1):10-19. PubMed ID: 33131380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey Analysis.
    Jhaveri J; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Wu EQ
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1398-1408. PubMed ID: 31566054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T; Palmer AJ
    Mult Scler Relat Disord; 2020 Sep; 44():102247. PubMed ID: 32554286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on healthcare resource utilization of multiple sclerosis in Spain.
    Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J
    BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Societal costs of multiple sclerosis in Ireland.
    Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
    J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
    Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
    J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
    [No Abstract]   [Full Text] [Related]  

  • 15. Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.
    Nicholas JA; Electricwala B; Lee LK; Johnson KM
    BMC Neurol; 2019 Oct; 19(1):258. PubMed ID: 31660897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical Region.
    Khandker RK; Ritchie CW; Black CM; Wood R; Jones E; Hu X; Ambegaonkar BM
    J Alzheimers Dis; 2020; 75(4):1141-1152. PubMed ID: 32390613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation.
    Du Y; Min R; Zhang X; Fang P
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):137-144. PubMed ID: 31984811
    [No Abstract]   [Full Text] [Related]  

  • 18. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
    Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
    Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
    Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V
    Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.